Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Prepaid Assets (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Prepaid Assets for 14 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 7.62% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 7.62% year-over-year, with the annual reading at $5.6 million for FY2025, 10.61% up from the prior year.
  • Prepaid Assets for Q4 2025 was $6.6 million at Aytu Biopharma, up from $5.2 million in the prior quarter.
  • The five-year high for Prepaid Assets was $71.1 million in Q2 2023, with the low at $624000.0 in Q4 2022.
  • Average Prepaid Assets over 5 years is $11.1 million, with a median of $5.6 million recorded in 2025.
  • The sharpest move saw Prepaid Assets plummeted 94.48% in 2022, then soared 11128.91% in 2023.
  • Over 5 years, Prepaid Assets stood at $11.3 million in 2021, then tumbled by 94.48% to $624000.0 in 2022, then soared by 113.62% to $1.3 million in 2023, then skyrocketed by 362.64% to $6.2 million in 2024, then rose by 7.62% to $6.6 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $6.6 million, $5.2 million, and $5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.